Past Events

ICTS Seminar - Al-Qa’ida: Sixteen Years after 9/11 and Beyond
ICTS Seminar - Al-Qa’ida: Sixteen Years after 9/11 and Beyond
Potomac Institute for Policy Studies International Center for Terrorism Studies As we mark the 16th anniversary of 9/11, is the worst yet to come? Will al-Qa’ida and its expanding network continue to threaten global security concerns? And what are the prospects of the U.S. and its allies to ult...
ICTS Seminar - Combating Biological Terrorism: Roadmaps for Global Strategies
ICTS Seminar - Combating Biological Terrorism: Roadmaps for Global Strategies
Potomac Institute for Policy Studies International Center for Terrorism Studies August 24, 2017 Biological security concerns are a permanent fixture of history, ranging from Mother Nature’s infectious diseases to man-made threats. Recent epidemics, such as Ebola and Zika, and the potential dan...

The Potomac Institute for Policy Studies hosts the Center for Revolutionary Scientific Thought (CReST), which harbors individuals from a variety of backgrounds to ensure a complete outlook on the futures of science and technology from an academic and policy perspective. CReST intends to inform the public and government officials, alike, about the most pressing issues and concerns regarding the future of science and technology. See one of our latest CReST blogs below:

The Future of AI in Healthcare: No Doctors Required

By Dr. Kathryn Ziden

Robotics and artificial intelligence (AI) are changing the field of healthcare. Doctors are seemingly open to this change, as long as there still is a place for them in the system. But is this a reality? Will we need doctors in the future? In the short term, yes. In the long term, not likely.

A recent study by the market research firm Frost & Sulllivan estimates the AI market in healthcare will exceed $6 billion by 2021. AI is already making big advances in automated soft-tissue surgery, medical imaging, drug discovery, and perhaps its biggest success so far: using big data analytics to diagnose and treat disease. IBM’s Watson is already being used at 16 cancer institutes, and recently correctly diagnosed a rare form of leukemia in a Japanese woman, after conventional (human) methods had failed.

Find the entire blog here.